Status:
COMPLETED
Negative Meta-cognitions as a Causal Factor to Worry
Lead Sponsor:
Karolinska Institutet
Conditions:
Excessive Worry
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to investigate if an internet-based metacognitive therapy reduces negative metacognitions and if reductions negative metacognitions mediates reductions in worry.
Detailed Description
The aim is primary mechanistic i.e. we want to investigate if a clear change in negative metacognitions in one group (internet-based metacognitive therapy; I-MCT) relative to another (waiting list) me...
Eligibility Criteria
Inclusion
- Outpatients
- ≥ 18 years
- Situated in Sweden
- Informed consent
- PSWQ score more than 56 points
Exclusion
- Substance dependence during the last six months
- Post traumatic stress disorder, bipolar disorder or psychosis
- Symptoms better explained by axis 2 diagnosis (e.g. autism or borderline personality disorder)
- MADRS-S score above 25 points
- Psychotropic medication changes within two months prior to treatment that could affect target symptoms.
- Received metacognitive therapy for pathological worry the last 2 years.
Key Trial Info
Start Date :
February 6 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 6 2018
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT03393156
Start Date
February 6 2018
End Date
May 6 2018
Last Update
August 7 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska Intitutet
Stockholm, Sweden, 17177